Congenital Heart Futures Reauthorization Act of 2024
Latest Action
Became Public Law No: 118-107.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Congenital Heart Futures Reauthorization Act of 2024 is a legislative measure from the 118th Congress aimed at continuing federal efforts related to congenital heart disease. Although the official summary and full text are not provided, the bill's title and policy area indicate it focuses on health initiatives concerning congenital heart conditions. The bill was introduced in the House and ultimately became Public Law No: 118-107 on November 21, 2024. However, the status is noted as Failed / Expired, suggesting it did not complete all legislative steps or was not enacted in its original form.
This bill sought to reauthorize federal programs addressing congenital heart disease but did not advance to full enactment as originally introduced.
- The bill is related to health policy, specifically congenital heart disease.
- It was introduced in the House during the 118th Congress as H.R. 7189.
- The latest recorded action states it became Public Law No: 118-107 on November 21, 2024, but the status is marked as Failed / Expired.
['Individuals affected by congenital heart disease', 'Health agencies involved in congenital heart disease research and treatment', 'Medical and public health organizations focused on heart health']
['Lack of available full bill text limits detailed understanding of provisions and funding mechanisms', 'The discrepancy between the bill becoming law and its status as Failed / Expired may indicate procedural or implementation challenges', 'Potential oversight and enforcement details are unknown due to missing text']
The bill was introduced in the House during the 118th Congress and relates to ongoing federal health initiatives addressing congenital heart disease. The legislative record shows it became Public Law No: 118-107, but the status indicates it did not fully pass or was superseded, reflecting complexities in the legislative process for health-related reauthorizations.
High concern review — 3 hidden impact flags detected
GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Continued federal focus on congenital heart disease may influence research funding priorities and healthcare provider training.', 'Potential impacts on insurance coverage or public health programs related to congenital heart conditions could arise from reauthorization efforts.', 'Legislative ambiguity or procedural issues might affect stakeholder confidence in related health initiatives.']
The absence of the full bill text and official summary limits transparency and public understanding of the bill's specific provisions and intended outcomes. Additionally, the conflicting information regarding the bill's status and enactment requires clarification to ensure accurate tracking of legislative progress and implementation. These gaps highlight the importance of complete and consistent legislative documentation for effective government transparency and oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.